"When you look at the benefits of the plant from a practical standpoint, the harm and cost reduction, the impact you have in terms of tax…
In Conversation
"No other country has grown cannabis at an industrial level before and we are well positioned to both develop and export best practices globally. We have…
With the initiation of a study on how to implement a national pharmacare program, we are hopeful that this may represent an opportunity to finally have…
"After the official merger of Zimmer and Biomet in June 2015, the Canadian affiliate was the first affiliate to be fully integrated last year."
"Our proximity with the USA allows us to be highly productive when looking for partnerships with US-based companies. We establish collaborations with them, in order to…
"Between 2009 and 2014, the company experienced a 100 percent growth in sales and a 50 percent improvement in productivity"
"Results do speak for themselves as close to 100 percent of the dossiers that myself or my team have supported through the Health Canada review process…
Our next area of growth will be in Oncology and we are looking forward to introducing some interesting innovative products in that therapeutic area
"We believe that a global paradigm shift around medical cannabis is upon us, and that the future winners of the industry will take the form of…
"From the very beginning, it was important to make sure that every decision was made through the lens of what is right for patients."
"We want to not only produce medicine, but applications and devices that will enhance either the experience or the outcome for the patient."
"We identified a proven, scalable model in Harvest Medicine and are now in the process of expanding it to four additional locations over the next 12…
